Focus-X Therapeutics, Inc. — Form D

Focus-X Therapeutics, Inc. of SAMMAMISH, WA, a company, filed a Form D exempt-offering notice with the SEC on 2020-09-22. The offering totals $3.0M, of which $1.5M was reported sold. Industry: Other Technology.

Offering

• Filed: 2020-09-22
• Form: D
• Accession: 0001567619-20-016966
• Industry: Other Technology
• Exemptions: 06b
• Total offering: $3.0M
• Amount sold: $1.5M
• Remaining: $1.5M
• Investors: 1
• Date of first sale: 2020-09-09
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-375977

Issuer

• Name: Focus-X Therapeutics, Inc.
• CIK: 0001825529
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2020
• Address: 3541 223RD AVE. SE., SAMMAMISH, WA, 98075
• Phone: 3175694884

Officers, directors & promoters (4)

More

• CIK 1825529 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search